Chenggong Yu

1.9k total citations · 1 hit paper
33 papers, 1.4k citations indexed

About

Chenggong Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Chenggong Yu has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in Chenggong Yu's work include Gastric Cancer Management and Outcomes (8 papers), Gut microbiota and health (8 papers) and Inflammatory Bowel Disease (6 papers). Chenggong Yu is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Gut microbiota and health (8 papers) and Inflammatory Bowel Disease (6 papers). Chenggong Yu collaborates with scholars based in China, United States and Australia. Chenggong Yu's co-authors include Mingming Zhang, Xiaotong Yang, Xinyun Qiu, Robert Dorfman, Qian Zhou, Lixing Zhou, Yuming Wang, Yida Pan, Dehua Tang and Lei Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Chenggong Yu

31 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1

2018 342 citations Lixing Zhou, Mingming Zhang et al. Inflammatory Bowel Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chenggong Yu China	18	879	243	242	208	180	33	1.4k
Roberto Ferrarese Italy	19	880 1.0×	279 1.1×	225 0.9×	224 1.1×	78 0.4×	36	1.6k
Liya Yang China	24	1.1k 1.3×	242 1.0×	209 0.9×	169 0.8×	91 0.5×	40	1.7k
Christopher D. Packey United States	9	767 0.9×	256 1.1×	174 0.7×	270 1.3×	68 0.4×	17	1.2k
Akihiko Oka Japan	22	514 0.6×	201 0.8×	379 1.6×	345 1.7×	125 0.7×	76	1.4k
Lucrezia Laterza Italy	18	430 0.5×	166 0.7×	423 1.7×	253 1.2×	203 1.1×	74	1.3k
Leiqi Xu China	14	957 1.1×	174 0.7×	175 0.7×	162 0.8×	65 0.4×	22	1.5k
Anthony J. Bilotta United States	11	1.0k 1.2×	245 1.0×	209 0.9×	196 0.9×	55 0.3×	20	1.5k
Shabnam Shahrokh Iran	22	529 0.6×	262 1.1×	224 0.9×	317 1.5×	70 0.4×	93	1.2k
Youlian Zhou China	24	1.4k 1.6×	393 1.6×	203 0.8×	358 1.7×	62 0.3×	55	1.9k
Marta Llopis Spain	16	1.2k 1.4×	276 1.1×	200 0.8×	179 0.9×	89 0.5×	23	1.9k

Countries citing papers authored by Chenggong Yu

Since Specialization

Citations

This map shows the geographic impact of Chenggong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenggong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenggong Yu more than expected).

Fields of papers citing papers by Chenggong Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenggong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenggong Yu. The network helps show where Chenggong Yu may publish in the future.

Co-authorship network of co-authors of Chenggong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenggong Yu. A scholar is included among the top collaborators of Chenggong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenggong Yu. Chenggong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Lei, Chenggong Yu, Xianghai Tang, et al.. (2025). Gene flow enhances genetic diversity and local adaptation in Pyropia yezoensis populations. Water Biology and Security. 5(1). 100411–100411.

Li, Na, et al.. (2025). Faecalibacterium prausnitzii Ameliorates DSS-Induced Colitis via Modulating Bile Acid Metabolism and Regulating FXR Signaling. Digestive Diseases and Sciences. 70(10). 3323–3339. 1 indexed citations

Li, Fuchao, Lei Liu, Xiaohong Wang, et al.. (2024). Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation. World Journal of Surgical Oncology. 22(1). 107–107. 1 indexed citations

Chen, Xiaotian, Mingming Zhang, Fan Zhou, et al.. (2023). SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis. Inflammatory Bowel Diseases. 29(12). 1929–1940. 17 indexed citations

Kong, Fanna, Bin Sun, Yunxiang Mao, et al.. (2023). Ethyl methanesulfonate mutant library construction in Neopyropia yezoensis to provide germplasm resources for next-generation genome-selection breeding. Frontiers in Marine Science. 10. 3 indexed citations

Gu, Zhengrong, et al.. (2022). Histone deacetylase 1 and 3 inhibitors alleviate colon inflammation by inhibiting Th17 cell differentiation. Journal of Clinical Laboratory Analysis. 36(10). e24699–e24699. 6 indexed citations

Wang, Chong‐Zhi, Haiqiang Yao, Chenggong Yu, et al.. (2019). Baicalein, an enteric microbial metabolite, suppresses gut inflammation and cancer progression in ApcMin/+ mice. Clinical & Translational Oncology. 22(7). 1013–1022. 51 indexed citations

Zhang, Xiaoqi, et al.. (2019). Artesunate exerts protective effects against ulcerative colitis via suppressing Toll‑like receptor 4 and its downstream nuclear factor‑κB signaling pathways. Molecular Medicine Reports. 20(2). 1321–1332. 24 indexed citations

Zhang, Mingming, Lixing Zhou, & Chenggong Yu. (2018). 128 - Faecalibacterium Prausnitzii Produces Butyrate to Maintain TH17/TREG Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1. Gastroenterology. 154(6). S–34. 6 indexed citations

10.

Zhou, Lixing, Mingming Zhang, Yuming Wang, et al.. (2018). Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1. Inflammatory Bowel Diseases. 24(9). 1926–1940. 342 indexed citations breakdown →

11.

Gong, Tao, Xiaqiong Wang, Yanqing Yang, et al.. (2017). Plant Lectins Activate the NLRP3 Inflammasome To Promote Inflammatory Disorders. The Journal of Immunology. 198(5). 2082–2092. 58 indexed citations

12.

Wang, Chong‐Zhi, Weihua Huang, Jin‐Yi Wan, et al.. (2017). Role of intestinal microbiome in American ginseng-mediated colon cancer protection in high fat diet-fed AOM/DSS mice. Clinical & Translational Oncology. 20(3). 302–312. 39 indexed citations

13.

Huang, Qin, Fang Cheng, Jiong Shi, et al.. (2015). Differences in Clinicopathology of Early Gastric Carcinoma between Proximal and Distal Location in 438 Chinese Patients. Scientific Reports. 5(1). 13439–13439. 56 indexed citations

14.

Qiu, Xinyun, et al.. (2013). Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. Journal of Crohn s and Colitis. 7(11). e558–e568. 219 indexed citations

15.

Gao, Qin‐Yan, Huimin Chen, Yingxuan Chen, et al.. (2013). Folic Acid Prevents the Initial Occurrence of Sporadic Colorectal Adenoma in Chinese Older than 50 Years of Age: A Randomized Clinical Trial. Cancer Prevention Research. 6(7). 744–752. 31 indexed citations

16.

Huang, Qin, Jiong Shi, Qi Sun, et al.. (2012). Distal esophageal carcinomas in Chinese patients vary widely in histopathology, but adenocarcinomas remain rare. Human Pathology. 43(12). 2138–2148. 26 indexed citations

17.

Gao, Qin‐Yan, Huimin Chen, Jianqiu Sheng, et al.. (2010). The first year follow-up after colorectal adenoma polypectomy is important: A multiple-center study in symptomatic hospital-based individuals in China. Frontiers of Medicine in China. 4(4). 436–442. 18 indexed citations

18.

Zhang, Shidong, et al.. (2009). Expression and significance of stem cell marker LGR5 proteins in the development and progression of human colorectal carcinoma.. Journal of Shandong University. 47(8). 85–135. 1 indexed citations

19.

Huang, Qin, Chenggong Yu, Xiaoqi Zhang, & Raj K. Goyal. (2008). Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma. BMC Clinical Pathology. 8(1). 5–5. 13 indexed citations

20.

Yu, Chenggong, Xiaoqi Zhang, Qin Huang, Michael A. Klein, & Raj K. Goyal. (2007). High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus. Laboratory Investigation. 87(5). 466–472. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact